Detalles de la búsqueda
1.
NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses.
Proc Natl Acad Sci U S A
; 112(11): E1333-42, 2015 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25739961
2.
Suppression of NYVAC Infection in HeLa Cells Requires RNase L but Is Independent of Protein Kinase R Activity.
J Virol
; 90(4): 2135-41, 2016 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26656695
3.
Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice.
J Virol
; 86(9): 5026-38, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22419805
4.
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens.
J Virol
; 85(21): 11468-78, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21865377
5.
Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens.
PLoS One
; 7(10): e48524, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23119046
6.
Diversity in viral anti-PKR mechanisms: a remarkable case of evolutionary convergence.
PLoS One
; 6(2): e16711, 2011 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-21311764
7.
A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses.
PLoS One
; 6(8): e24244, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21909386
8.
Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions.
PLoS One
; 5(8): e12395, 2010 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20811493
9.
Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens.
PLoS One
; 5(6): e11406, 2010 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20613977
10.
Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice.
J Gen Virol
; 88(Pt 9): 2473-2478, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17698656
11.
Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.
J Virol
; 81(16): 8707-21, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17537851
12.
Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
Vaccine
; 25(15): 2863-85, 2007 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-17113200
13.
Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
Vaccine
; 25(11): 1969-92, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17224219
14.
Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells.
J Virol
; 80(2): 985-98, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16379000
15.
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.
J Virol
; 80(12): 6033-47, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16731942
16.
Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
J Immunol
; 172(10): 6209-20, 2004 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15128809
17.
Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
J Virol
; 77(12): 7048-57, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12768024
Resultados
1 -
17
de 17
1
Próxima >
>>